Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Expert opinion on investigational drugs - 26(2017), 2, Seite 133-136 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jäger, Tarkan [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| doi: |
10.1080/13543784.2017.1274392 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1989437532 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1989437532 | ||
| 003 | DE-627 | ||
| 005 | 20230508060205.0 | ||
| 007 | tu | ||
| 008 | 170207s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1080/13543784.2017.1274392 |2 doi | |
| 028 | 5 | 2 | |a PQ20170301 |
| 035 | |a (DE-627)OLC1989437532 | ||
| 035 | |a (DE-599)GBVOLC1989437532 | ||
| 035 | |a (PRQ)c702-b5f127e5dc9bbdb16105e5d55a260fb6485669b690fa49fd6745a6d5080c84d80 | ||
| 035 | |a (KEY)0225658420170000026000200133thoughtsoninvestigationalhedgehogpathwayinhibitors | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Jäger, Tarkan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Ocker, Matthias |4 oth | |
| 700 | 1 | |a Kiesslich, Tobias |4 oth | |
| 700 | 1 | |a Neureiter, Elen |4 oth | |
| 700 | 1 | |a Neureiter, Daniel |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on investigational drugs |d London : Informa Healthcare, 1994 |g 26(2017), 2, Seite 133-136 |w (DE-627)182171841 |w (DE-600)1182884-5 |w (DE-576)435516485 |x 1354-3784 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2017 |g number:2 |g pages:133-136 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1080/13543784.2017.1274392 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 26 |j 2017 |e 2 |h 133-136 | ||